14K.F · Sundial Growers Inc

-

Please sign in to comment on 14K.F

1 Comment

Admin

4 years, 1 month ago

Sundial Growers Inc is currently in a long term uptrend where the price is trading 11.8% above its 200 day moving average.

From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.0.

Sundial Growers Inc's total revenue sank by 35.7% to $14M since the same quarter in the previous year.

Its net income has increased by 55.8% to $-64M since the same quarter in the previous year.

Finally, its free cash flow grew by 84.8% to $-12M since the same quarter in the previous year.

Based on the above factors, Sundial Growers Inc gets an overall score of 4/5.

Exchange	F
CurrencyCode	EUR
ISIN	None
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

Market Cap	661M
PE Ratio	None
Target Price	0.7
Dividend Yield	0.0%
Beta	4.87

ABOUT

Sundial Growers Inc

Sundial Growers Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Cannabis Operations and Retail Operations segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use markets; and private sale of recreational cannabis through corporate owned and franchised retail cannabis stores. The company also produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. Sundial Growers Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.

14K.F · Sundial Growers Inc

-

Sundial Growers Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Sundial Growers Inc using a moving average strategy